Lumenis’ ground-breaking products using laser, intense pulsed light (IPL) and radio frequency (RF) technologies have redefined medical treatments and set numerous technological and clinical benchmarks and standards.

By utilizing Cognizant’s MedVantage Complaint Management Solution, device and other issues are automatically and precisely tracked, classified and maintained online from start to finish for improved service, efficiency and reporting.

"Lumenis has an uncompromising commitment to improving the health and well-being of our patients. The Cognizant MedVantage solution integrates seamlessly with our existing infrastructure and provides all of our stakeholders with a critical end-to-end complaint management solution," said Amir Belferman, Global CIO, Lumenis.

"MedVantage enables us to not only manage product complaints but also related adverse events, Medical Device Reporting (MDR)/Vigilance reporting, corrective and preventive action (CAPA) activities, and internal/external audit tracking. Our regional offices recently went ‘live’ with this new solution, enhancing our ability to analyze global post market data from anywhere in the world."

"With Lumenis deploying more of its innovative medical devices worldwide, it is leveraging the scale of the cloud to implement a highly collaborative digital solution that can be quickly adopted in multiple markets," said Shankar Narayanan, Vice President and Global Markets Leader of the Life Sciences practice at Cognizant.

Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology, and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF).